Health :: Marburg hemorrhagic fever

Marburg hemorrhagic fever is a rare, severe type of hemorrhagic fever which affects both humans and non-human primates. Caused by a genetically unique zoonotic (that is, animal-borne) RNA virus of the filovirus family, its recognition led to the creation of this virus family. The four species of Ebola virus are the only other known members of the filovirus family.

Diabetes :: New drug to treat type 1 and type 2 diabetes

The Food and Drug Administration (FDA) approved Symlin, an injectable medicine to control blood sugar for adults with type 1 and type 2 diabetes. Symlin is to be used in addition to insulin therapy in patients who cannot achieve adequate control of their blood sugars on intensive insulin therapy alone.

Aging :: Homoeopathy & geriatrics, old age

Gerontology is the study of old age, stressing the social and behavioral looks of aging. Although aging is a lifelong process and changes in its effects on individual people, old age has been generally stated as beginning at the age of 65.

Nutrition :: Major Initiatives for Dietary Supplements

The Food and Drug Administration announced three major regulatory initiatives designed to further implement the Dietary Supplement Health and Education Act of 1994 (DSHEA). These initiatives — a regulatory strategy, an open public meeting, and a draft guidance document for industry — are significant steps FDA has taken in the implementation of DSHEA.

Obesity :: Steps for safe and effective weight loss for overweight and obesity

In 1999, almost 108 million adult Americans were overweight or obese. If you are overweight or obese, carrying this extra weight puts you at risk for developing many diseases, especially heart disease, stroke, diabetes, and cancer. Losing this weight helps to prevent and control these diseases. Following guidelines provide you with a new approach for the measurement of overweight and obesity and a set of steps for safe and effective weight loss.